Patents by Inventor Satoshi Kishida

Satoshi Kishida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9840552
    Abstract: A monoclonal antibody, which recognizes at least two amino acids among amino acids located at position 69, position 79, position 81 and position 102 of human midkine, has been found to have excellent reactivity with and excellent neutralizing activity against human midkine. Moreover, the activity of suppressing the proliferation of tumor has been observed in the antibody having excellent neutralizing activity. The use of the antibody of the present invention makes it possible to treat cancer effectively and to detect or purify midkine efficiently.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: December 12, 2017
    Assignees: NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY, MEDICAL & BIOLOGICAL LABORATORIES CO., LTD.
    Inventors: Kenji Kadomatsu, Satoshi Kishida, Kenichiro Ono, Kasumi Yagi
  • Publication number: 20150203573
    Abstract: A monoclonal antibody, which recognizes at least two amino acids among amino acids located at position 69, position 79, position 81 and position 102 of human midkine, has been found to have excellent reactivity with and excellent neutralizing activity against human midkine. Moreover, the activity of suppressing the proliferation of tumor has been observed in the antibody having excellent neutralizing activity. The use of the antibody of the present invention makes it possible to treat cancer effectively and to detect or purify midkine efficiently.
    Type: Application
    Filed: July 30, 2013
    Publication date: July 23, 2015
    Applicants: MEDICAL & BIOLOGICAL LABORATORIES CO., LTD., NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY
    Inventors: Kenji Kadomatsu, Satoshi Kishida, Kenichiro Ono, Kasumi Yagi
  • Publication number: 20100013825
    Abstract: This invention provides a display device constituted of a display panel in which pixels including light-emitting elements E11 to Emn are connected in the form of a matrix at each intersection between a plurality of data lines A1 to Am and a plurality of scan lines K1 to Kn, a scan driver connected to the scan lines and selectively scanning each of the scan lines, and a data driver supplying a display signal to each of the pixels. Timings of charging and discharging a charge, charged and discharged in a parasitic capacitance of each of the light emitting elements, are dispersed, and a level of radiation noise generated at this time can be reduced.
    Type: Application
    Filed: March 14, 2007
    Publication date: January 21, 2010
    Applicants: PIONEER CORPORATION, TOHOKU PIONEER CORPORATION
    Inventors: Hiroyuki Takahashi, Satoshi Kishida, Yoshimasa Kaneko
  • Patent number: 6242565
    Abstract: A method for preparing a peptide derivative of formula (I) or a salt thereof: which method comprises the steps of removing two MBzl groups from a compound of formula (II) or a salt thereof: wherein MBzl represents a 4-methoxybenzyl group which serves as a protective group for a thiol group, and R1 and R2 represent hydrogen or a protective group for Trp or Arg respectively; and subsequently oxidizing in an aqueous medium having a pH from 4 to 6 to form an intramolecular disulphide bond; intermediates useful for preparing the compounds of formula (I) and preparation of the intermediates.
    Type: Grant
    Filed: August 5, 1998
    Date of Patent: June 5, 2001
    Assignee: TT Pharmaceuticals, Inc.
    Inventors: Satoshi Kishida, Akihiro Nakanishi, Hitoshi Kimura
  • Patent number: 5508382
    Abstract: A peptide of the following general formula is subjected to cyclization reaction to produce a cyclic peptide, preferably a synthetic calcitonin derivative (elcatonin) which is a useful medicine. ##STR1## (wherein A and B form a peptide of the formula Ser-Asn-Leu-Ser-Thr (SEQ ID NO: 43); X means a hydroxyl group, a carboxy-protecting group, an amino acid residue or a peptide residue; provided that the side-chain carboxyl group of .alpha.-L-aminosuberic acid is condensed with an amino acid or a peptide). The cyclic peptide can be obtained by subjecting a peptide of the above general formula to (1) cyclization reaction by chemical condensation, (2) cyclization reaction in the presence of an alkali metal salt and (3) reactions using the techniques of liquid phase synthesis and solid phase synthesis in combination.
    Type: Grant
    Filed: June 28, 1993
    Date of Patent: April 16, 1996
    Assignee: Daicel Chemical Industries, Ltd.
    Inventors: Masutaka Ohsaki, Satoshi Kishida, Takashi Inoue
  • Patent number: 5428129
    Abstract: In this invention, a peptide of the following general formula is subjected to cyclization reaction to produce a cyclic peptide, preferably a synthetic calcitonin derivative (elcatonin) which is a useful medicine. ##STR1## (wherein A and B form a peptide of the formula Ser-Asn-Leu-Ser-Thr (SEQ ID NO: 47); X means a hydroxyl group, a carboxy-protecting group, an amino acid residue or a peptide residue; provided that the side-chain carboxyl group of .alpha.-L-aminosuberic acid is condensed with an amino acid or a peptide).The cyclic peptide can be obtained by subjecting a peptide of the above general formula to (1) cyclization reaction by chemical condensation, (2) cyclization reaction in the presence of an alkali metal salt and (3) reactions using the techniques of liquid phase synthesis and solid phase synthesis in combination.
    Type: Grant
    Filed: July 8, 1991
    Date of Patent: June 27, 1995
    Assignee: Daicel Chemical Industries
    Inventors: Masutaka Ohsaki, Satoshi Kishida, Takashi Inoue